Cardiac Arrhythmias and Arrhythmogenic Disorders: Technological Frontiers, Drug Development and Future Directions

Dear Colleagues,

This Special Issue is dedicated to exploring advances in cardiac arrhythmias and arrhythmogenic disorders. The scope involves the following key areas.

Diagnostic innovations: Within this issue, we seek contributions that explore innovative diagnostic tools and technologies. These contributions should emphasize novel approaches for the early detection and precise characterization of various cardiac arrhythmias.

Therapeutic breakthroughs: This Special Issue welcomes articles presenting groundbreaking advancements in therapeutic interventions. This includes (but is not limited to) targeted drug therapies, the development of novel antiarrhythmic agents, neuromodulation therapies, and innovations in catheter ablation techniques. We aim to highlight studies that are reshaping the treatment paradigm for patients with cardiac arrhythmias.

Technological frontiers: We encourage submissions that investigate the role of cutting-edge technologies in reshaping the landscape of cardiac arrhythmia management. This includes the application of artificial intelligence, wearable devices, and remote monitoring systems. Articles in this domain should explore how these technological frontiers assist patients in monitoring, predicting, and managing arrhythmic conditions.

Future directions: This Special Issue aims to encourage discussions on the challenges existing in the field and propose future directions for cardiac arrhythmia research. Authors can present their perspectives on addressing gaps in current knowledge and envisioning innovative solutions that will lead to future advancements in understanding and managing cardiac arrhythmias.

We would like to invite researchers and clinicians to contribute their expertise and insights to this Special Issue, which will advance the science and clinical practice surrounding cardiac arrhythmias.

Dr. Siamak Salavatian
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• cardiac arrhythmias
• arrhythmias diagnostic
• arrhythmias therapy
• technological frontiers
• personalized medicine
• biomarkers
• neuromodulation
• artificial intelligence

Differential Cardiotoxicity Associated with Proteasome Inhibitors Using the FDA Adverse Drug Reporting System Data